Huayi Capital

HY Capital is a venture capital firm established in 2015 and based in Shanghai, China. The firm focuses on the healthcare industry, specializing in early-stage and growth-stage investments. By targeting innovative companies within the healthcare sector, HY Capital aims to support the development of new technologies and solutions that can improve patient care and health outcomes.

Feng Cao

Founding Partner

Yun Liu Ph.D

Founding Partner and Chairman of the Board

12 past transactions

Chinagene Tech

Series A in 2022
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Yijian Health

Seed Round in 2022
Yijian Health is a one-stop precision medicine service platform. Its core products include genetic testing services and LIMS system software. It is mainly engaged in gene sequencing for individualized medication guidance for tumors, women and children, infections, chronic diseases and other diseases, providing professional testing for the general public. Serve.

ChosenMed

Series B in 2020
ChosenMed is a Healthcare company based in Beijing.

Zhizu Tech

Series A in 2019
Zhizu Tech, officially known as Shanghai Zhizu Logistics Technology Co., Ltd., is a Shanghai-based company founded in 2018 that specializes in developing software and services for end-to-end distribution lease providers. The company offers solutions tailored for express delivery firms and food ordering platforms, enabling them to plan and manage their distribution fleets effectively. Its offerings include delivery vehicle rental services, smart battery swaps, and an IoT cloud management platform. Additionally, Zhizu Tech provides offline maintenance services and builds AI-based data systems to enhance vehicle connectivity. By focusing on logistics and delivery, the company aims to streamline operations and improve efficiency in the instant delivery sector.

MFA

Series A in 2019
MFA members say that it is a skin care platform that aims to make more and better skin care products go from the laboratory to the consumer market, so that more people can enjoy the life change caused by skin care.MFA members said that it is a membership-based beauty and e-commerce platform. It is committed to creating a platform model featuring annual membership e-commerce, relying on its own perfect supply chain advantages to create a “closed eye to buy for the public, big-name quality is not expensive. The shopping experience has been recognized by the consumer market and has a wide growing space.

Cloudbreak Therapeutics

Series A in 2018
Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.

Fushoukang

Series A in 2018
Shanghai Fushoukang Rehabilitative Home Nursing Services specializes in in-home rehabilitation and nursing care for the elderly, as well as individuals who are weak, sick, or disabled. Founded in 2011 and headquartered in Shanghai, the company offers a range of services including home care, community care, nursing care, and bathing assistance. By focusing on the needs of vulnerable populations, Fushoukang aims to enhance the quality of life for its clients through personalized care in the comfort of their own homes.

Fushoukang

Angel Round in 2018
Shanghai Fushoukang Rehabilitative Home Nursing Services specializes in in-home rehabilitation and nursing care for the elderly, as well as individuals who are weak, sick, or disabled. Founded in 2011 and headquartered in Shanghai, the company offers a range of services including home care, community care, nursing care, and bathing assistance. By focusing on the needs of vulnerable populations, Fushoukang aims to enhance the quality of life for its clients through personalized care in the comfort of their own homes.

Laviana Pharma

Series B in 2018
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.

Symbow Medical

Series A in 2017
Symbow Medical Technology Co., Ltd. is a Beijing-based company that specializes in the manufacture and distribution of medical devices focused on tumor early diagnosis and minimally invasive treatment solutions. Founded in 2011, the company offers innovative products such as Megrez navigation systems and dual-modality breast imagers that utilize diffusion optical tomography and ultrasound technologies. Symbow Medical's products are distributed through various channels both in China and internationally, aiming to enhance diagnostic accuracy and treatment precision in the medical field.

Shudouzhe

Seed Round in 2016
Developer of a SaaS financial software in China. The company is mainly engaged in offering finance and taxation consulting services and developing SaaS financial software, providing users with high quality financial service and SaaS software at a low cost.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.